WallStreetZenWallStreetZen

NASDAQ: NGNE
Neurogene Inc Stock Forecast, Predictions & Price Target

Analyst price target for NGNE

Based on 4 analysts offering 12 month price targets for Neurogene Inc.
Min Forecast
$31.00-0.03%
Avg Forecast
$45.50+46.73%
Max Forecast
$54.00+74.14%

Should I buy or sell NGNE stock?

Based on 4 analysts offering ratings for Neurogene Inc.
Strong Buy
Strong Buy
1 analysts 25%
Buy
3 analysts 75%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NGNE stock forecasts and price targets.

NGNE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-06-20
lockedlocked$00.00+00.00%2024-06-11
lockedlocked$00.00+00.00%2024-04-29
lockedlocked$00.00+00.00%2024-01-05

1 of 1

Forecast return on equity

Is NGNE forecast to generate an efficient return?
Company
-44.16%
Industry
76.61%
Market
81.23%
NGNE's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NGNE forecast to generate an efficient return on assets?
Company
-38.61%
Industry
31.22%
NGNE is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NGNE earnings per share forecast

What is NGNE's earnings per share in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
-$4.15-113.08%
Avg 2 year Forecast
-$4.07-112.82%
Avg 3 year Forecast
-$4.76-114.97%

NGNE revenue forecast

What is NGNE's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$28.7M

NGNE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NGNE$31.01$45.50+46.73%Strong Buy
ACIU$4.05$12.00+196.30%Strong Buy
SLRN$4.08$15.50+279.90%Buy
RNAC$22.80$45.00+97.37%Buy
ENGN$9.00$34.40+282.22%Strong Buy

Neurogene Stock Forecast FAQ

Is Neurogene Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: NGNE) stock is to Strong Buy NGNE stock.

Out of 4 analysts, 1 (25%) are recommending NGNE as a Strong Buy, 3 (75%) are recommending NGNE as a Buy, 0 (0%) are recommending NGNE as a Hold, 0 (0%) are recommending NGNE as a Sell, and 0 (0%) are recommending NGNE as a Strong Sell.

If you're new to stock investing, here's how to buy Neurogene stock.

What is NGNE's earnings growth forecast for 2024-2026?

(NASDAQ: NGNE) Neurogene's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.34%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.95%.

Neurogene's earnings in 2024 is -$39,034,000.On average, 5 Wall Street analysts forecast NGNE's earnings for 2024 to be -$53,920,121, with the lowest NGNE earnings forecast at -$59,319,921, and the highest NGNE earnings forecast at -$47,897,266. On average, 5 Wall Street analysts forecast NGNE's earnings for 2025 to be -$52,855,737, with the lowest NGNE earnings forecast at -$67,108,094, and the highest NGNE earnings forecast at -$41,147,516.

In 2026, NGNE is forecast to generate -$61,721,274 in earnings, with the lowest earnings forecast at -$68,665,729 and the highest earnings forecast at -$54,776,820.

What is NGNE's revenue growth forecast for 2028-2028?

(NASDAQ: NGNE) Neurogene's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.7%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.86%.

Neurogene's revenue in 2024 is $0.

In 2028, NGNE is forecast to generate $372,573,235 in revenue, with the lowest revenue forecast at $372,573,235 and the highest revenue forecast at $372,573,235.

What is NGNE's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: NGNE) forecast ROA is -38.61%, which is lower than the forecast US Biotechnology industry average of 31.22%.

What is NGNE's Price Target?

According to 4 Wall Street analysts that have issued a 1 year NGNE price target, the average NGNE price target is $45.50, with the highest NGNE stock price forecast at $54.00 and the lowest NGNE stock price forecast at $31.00.

On average, Wall Street analysts predict that Neurogene's share price could reach $45.50 by Jun 20, 2025. The average Neurogene stock price prediction forecasts a potential upside of 46.73% from the current NGNE share price of $31.01.

What is NGNE's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: NGNE) Neurogene's current Earnings Per Share (EPS) is $31.76. On average, analysts forecast that NGNE's EPS will be -$4.15 for 2024, with the lowest EPS forecast at -$4.57, and the highest EPS forecast at -$3.69. On average, analysts forecast that NGNE's EPS will be -$4.07 for 2025, with the lowest EPS forecast at -$5.17, and the highest EPS forecast at -$3.17. In 2026, NGNE's EPS is forecast to hit -$4.76 (min: -$5.29, max: -$4.22).

What is NGNE's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: NGNE) forecast ROE is -44.16%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.